PDL BioPharma, Inc.Redwood City, CA, United States (NASDAQ (GS): PDLI)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

PDL Income Statement

All amounts in millions of except per share amounts.
View: Annual | Quarterly
Dec 07 Dec 06 Dec 05
Revenue 258.9 414.8 279.6
Cost of Goods Sold -- 86.3 60.3
Gross Profit -- 328.5 219.4
Gross Profit Margin 0.0% 79.2% 78.5%
SG&A Expense 216.9 384.4 329.6
Depreciation & Amortization 66.8 78.0 54.9
Operating Income (24.8) (133.9) (165.1)
Operating Margin -- -- --
Nonoperating Income 19.4 17.7 9.6
Nonoperating Expenses 13.7 13.1 10.2
Income Before Taxes (19.1) (129.3) (165.7)
Income Taxes 0.3 0.8 0.9
Net Income After Taxes (19.4) (130.0) (166.6)

Continuing Operations (19.4) (130.0) (166.6)
Discontinued Operations (1.7) -- --
Total Operations (21.1) (130.0) (166.6)
Total Net Income (21.1) (130.0) (166.6)
Net Profit Margin -- -- --

Diluted EPS from Total Net Income ($) (0.18) (1.14) (1.60)
Dividends per Share -- -- --
Edgar Online logo
This data is provided as per license from EDGAR Online